Cargando…

The Role of SATB1 in Tumour Progression and Metastasis

Carcinogenesis is a long-drawn, multistep process, in which metastatic spread is an unequivocal hallmark of a poor prognosis. The progression and dissemination of epithelial cancers is commonly thought to rely on the epidermal-mesenchymal transition (EMT) process. During EMT, epithelial cells lose t...

Descripción completa

Detalles Bibliográficos
Autores principales: Glatzel-Plucińska, Natalia, Piotrowska, Aleksandra, Dzięgiel, Piotr, Podhorska-Okołów, Marzenna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747166/
https://www.ncbi.nlm.nih.gov/pubmed/31450715
http://dx.doi.org/10.3390/ijms20174156
_version_ 1783451838589173760
author Glatzel-Plucińska, Natalia
Piotrowska, Aleksandra
Dzięgiel, Piotr
Podhorska-Okołów, Marzenna
author_facet Glatzel-Plucińska, Natalia
Piotrowska, Aleksandra
Dzięgiel, Piotr
Podhorska-Okołów, Marzenna
author_sort Glatzel-Plucińska, Natalia
collection PubMed
description Carcinogenesis is a long-drawn, multistep process, in which metastatic spread is an unequivocal hallmark of a poor prognosis. The progression and dissemination of epithelial cancers is commonly thought to rely on the epidermal-mesenchymal transition (EMT) process. During EMT, epithelial cells lose their junctions and apical-basal polarity, and they acquire a mesenchymal phenotype with its migratory and invasive capabilities. One of the proteins involved in cancer progression and EMT may be SATB1 (Special AT-Rich Binding Protein 1)—a chromatin organiser and a global transcriptional regulator. SATB1 organizes chromatin into spatial loops, providing a “docking site” necessary for the binding of further transcription factors and chromatin modifying enzymes. SATB1 has the ability to regulate whole sets of genes, even those located on distant chromosomes. SATB1 was found to be overexpressed in numerous malignancies, including lymphomas, breast, colorectal, prostate, liver, bladder and ovarian cancers. In the solid tumours, an elevated SATB1 level was observed to be associated with an aggressive phenotype, presence of lymph node, distant metastases, and a poor prognosis. In this review, we briefly describe the prognostic significance of SATB1 expression in most common human cancers, and analyse its impact on EMT and metastasis.
format Online
Article
Text
id pubmed-6747166
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67471662019-09-27 The Role of SATB1 in Tumour Progression and Metastasis Glatzel-Plucińska, Natalia Piotrowska, Aleksandra Dzięgiel, Piotr Podhorska-Okołów, Marzenna Int J Mol Sci Review Carcinogenesis is a long-drawn, multistep process, in which metastatic spread is an unequivocal hallmark of a poor prognosis. The progression and dissemination of epithelial cancers is commonly thought to rely on the epidermal-mesenchymal transition (EMT) process. During EMT, epithelial cells lose their junctions and apical-basal polarity, and they acquire a mesenchymal phenotype with its migratory and invasive capabilities. One of the proteins involved in cancer progression and EMT may be SATB1 (Special AT-Rich Binding Protein 1)—a chromatin organiser and a global transcriptional regulator. SATB1 organizes chromatin into spatial loops, providing a “docking site” necessary for the binding of further transcription factors and chromatin modifying enzymes. SATB1 has the ability to regulate whole sets of genes, even those located on distant chromosomes. SATB1 was found to be overexpressed in numerous malignancies, including lymphomas, breast, colorectal, prostate, liver, bladder and ovarian cancers. In the solid tumours, an elevated SATB1 level was observed to be associated with an aggressive phenotype, presence of lymph node, distant metastases, and a poor prognosis. In this review, we briefly describe the prognostic significance of SATB1 expression in most common human cancers, and analyse its impact on EMT and metastasis. MDPI 2019-08-25 /pmc/articles/PMC6747166/ /pubmed/31450715 http://dx.doi.org/10.3390/ijms20174156 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Glatzel-Plucińska, Natalia
Piotrowska, Aleksandra
Dzięgiel, Piotr
Podhorska-Okołów, Marzenna
The Role of SATB1 in Tumour Progression and Metastasis
title The Role of SATB1 in Tumour Progression and Metastasis
title_full The Role of SATB1 in Tumour Progression and Metastasis
title_fullStr The Role of SATB1 in Tumour Progression and Metastasis
title_full_unstemmed The Role of SATB1 in Tumour Progression and Metastasis
title_short The Role of SATB1 in Tumour Progression and Metastasis
title_sort role of satb1 in tumour progression and metastasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747166/
https://www.ncbi.nlm.nih.gov/pubmed/31450715
http://dx.doi.org/10.3390/ijms20174156
work_keys_str_mv AT glatzelplucinskanatalia theroleofsatb1intumourprogressionandmetastasis
AT piotrowskaaleksandra theroleofsatb1intumourprogressionandmetastasis
AT dziegielpiotr theroleofsatb1intumourprogressionandmetastasis
AT podhorskaokołowmarzenna theroleofsatb1intumourprogressionandmetastasis
AT glatzelplucinskanatalia roleofsatb1intumourprogressionandmetastasis
AT piotrowskaaleksandra roleofsatb1intumourprogressionandmetastasis
AT dziegielpiotr roleofsatb1intumourprogressionandmetastasis
AT podhorskaokołowmarzenna roleofsatb1intumourprogressionandmetastasis